Canopy Growth Corporation
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
10
Active:0
Completed:5
Trial Phases
2 Phases
Phase 1:3
Phase 2:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (66.7%)Phase 1
3 (33.3%)A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality
Phase 1
Completed
- Conditions
- Healthy Adults
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 301
- Registration Number
- NCT05839964
- Locations
- 🇺🇸
Remote, Fayetteville, Arkansas, United States
The Effects of CBD Isolate on Menstrual-Related Symptoms
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT05679830
- Locations
- 🇺🇸
James Madison University, Harrisonburg, Virginia, United States
CBD in Postmenopausal Women With Osteopenia
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 2
- Registration Number
- NCT05317013
- Locations
- 🇺🇸
NM Clinical Research & Osteoporosis Center, Inc., Albuquerque, New Mexico, United States
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy Adults
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT05210634
- Locations
- 🇺🇸
Nucleus Network, Saint Paul, Minnesota, United States
Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity
Phase 2
Completed
- Conditions
- Delayed Onset Muscle Soreness (DOMS)
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT05026164
- Locations
- 🇺🇸
International Society for Sports Nutrition, Boca Raton, Florida, United States
- Prev
- 1
- 2
- Next
News
Canopy Growth Expands German Medical Cannabis Portfolio with Tweed Brand Launch
Canopy Growth has introduced its established Tweed brand to the German medical cannabis market, launching four new EU-cultivated strains through a partnership with Portuguese cultivator Gro-Vida.